Omeprotect (Omeprazole)

Omeprazole, the active ingredient in Omeprotect, is a proton pump inhibitor presented as a oral dosage form for gastrointestinal acid‑related condition use. It reduces stomach acid production and is commonly prescribed for adults with conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease.

GNH USA supplies Omeprotect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprotect is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and erosive esophagitis. - Peptic ulcer disease (PUD): promotes ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - NSAID‑induced ulcer prophylaxis: lowers risk of ulcer formation in chronic NSAID users. - H‑